Optimizing orthodontic treatment in patients taking bisphosphonates for osteoporosis
- 1 March 2009
- journal article
- case report
- Published by Elsevier in American Journal of Orthodontics and Dentofacial Orthopedics
- Vol. 135 (3) , 361-374
Abstract
No abstract availableKeywords
This publication has 50 references indexed in Scilit:
- OsteopeniaNew England Journal of Medicine, 2007
- Postmenopausal OsteoporosisNew England Journal of Medicine, 2005
- Screening for OsteoporosisNew England Journal of Medicine, 2005
- Discovery, Clinical Development, and Therapeutic Uses of BisphosphonatesAnnals of Pharmacotherapy, 2005
- New Insights Into the Molecular Mechanisms of Action of BisphosphonatesCurrent Pharmaceutical Design, 2003
- Bisphosphonates suppress bone resorption by a direct effect on early osteoclast precursors without affecting the osteoclastogenic capacity of osteogenic cells: the role of protein geranylgeranylation in the action of nitrogencontaining bisphosphonates on osteoclast precursorsBone, 2002
- Cellular and molecular mechanisms of action of bisphosphonatesCancer, 2000
- TREATMENT OF OSTEOPOROSIS WITH BISPHOSPHONATESEndocrinology and Metabolism Clinics of North America, 1998
- The Osteoporosis RevolutionAnnals of Internal Medicine, 1997
- Comparison of the distribution of 3H-alendronate and 3H-Etidronate in rat and mouse bonesBone, 1996